Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rothenberg

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Cancer Treatment and Research|January 1, 1994
DNA ploidy and S-phase fraction as prognostic factors in cervical cancerM L Rothenberg
The Oncologist|February 13, 2001
Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyondM L Rothenberg
Oncology (Williston Park, N.Y.)|January 11, 2003
Current status of capecitabine in the treatment of colorectal cancerMace L Rothenberg
Seminars in Oncology|February 1, 1996
CPT-11: an original spectrum of clinical activityM L Rothenberg
Annals of the New York Academy of Sciences|December 13, 1996
The current status of irinotecan (CPT-11) in the United StatesM L Rothenberg
Oncology (Williston Park, N.Y.)|February 24, 2001
Efficacy of oxaliplatin in the treatment of colorectal cancerM L Rothenberg
Clinical Colorectal Cancer|June 24, 2004
Current status of second-line therapy for metastatic colorectal cancerMace L Rothenberg
Bulletin of the Medical Library Association|April 1, 1970
An analysis of the demographic, educational, and employment characteristics of participants in the continuing education program of the Medical Library Association, Denver, Colorado, June 1968A M Rees, L Rothenberg
Cancer Chemotherapy Reports|October 1, 1970
Commentary. Management of the National Cancer Institute's drug research program through application of the linear array conceptL Rothenberg, R A Terselic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Therapeutic strategies for metastatic colorectal cancer: simultaneous, sequential, or specific?Mace L Rothenberg, Jordan D Berlin
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Cancer Treatment and Research|January 1, 1994
DNA ploidy and S-phase fraction as prognostic factors in cervical cancerM L Rothenberg
The Oncologist|February 13, 2001
Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyondM L Rothenberg
Oncology (Williston Park, N.Y.)|January 11, 2003
Current status of capecitabine in the treatment of colorectal cancerMace L Rothenberg
Seminars in Oncology|February 1, 1996
CPT-11: an original spectrum of clinical activityM L Rothenberg
Annals of the New York Academy of Sciences|December 13, 1996
The current status of irinotecan (CPT-11) in the United StatesM L Rothenberg
Oncology (Williston Park, N.Y.)|February 24, 2001
Efficacy of oxaliplatin in the treatment of colorectal cancerM L Rothenberg
Clinical Colorectal Cancer|June 24, 2004
Current status of second-line therapy for metastatic colorectal cancerMace L Rothenberg
Bulletin of the Medical Library Association|April 1, 1970
An analysis of the demographic, educational, and employment characteristics of participants in the continuing education program of the Medical Library Association, Denver, Colorado, June 1968A M Rees, L Rothenberg
Cancer Chemotherapy Reports|October 1, 1970
Commentary. Management of the National Cancer Institute's drug research program through application of the linear array conceptL Rothenberg, R A Terselic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Therapeutic strategies for metastatic colorectal cancer: simultaneous, sequential, or specific?Mace L Rothenberg, Jordan D Berlin
Pageof 17